Tirzepatide commonly causes nausea, vomiting, diarrhea, and constipation, particularly during dose escalation
This decline is a natural part of aging and can contribute to: Any of this sound familiar
Similar content being viewed by others Introduction In 2023, several landmark trials with the potential to change clinical practice were presented at major international meetings including the American College of Cardiology (ACC), European Association for Percutaneous Cardiovascular Interventions (EuroPCR), European Society of Cardiology (ESC), Transcatheter Cardiovascular Therapeutics (TCT), American Heart Association (AHA), European Heart Rhythm Association (EHRA), Society for Cardiovascular Angiography and Interventions (SCAI), TVT-The Heart Summit (TVT) and Cardiovascular Research Technologies (CRT)
State Regulatory Actions 18 state boards of pharmacy and medicine have issued direct alerts to licensees about compounded GLP-1 medications, like this one from the Idaho Division of Occupational and Professional Licenses